duloxetine hydrochloride has been researched along with 2019 Novel Coronavirus Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manu, P | 1 |
| Ebell, MH; Grad, R | 1 |
2 other study(ies) available for duloxetine hydrochloride and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Repurposing Drugs for Post-COVID-19 Fatigue Syndrome: Methylphenidate, Duloxetine, and Brexpiprazole.
Topics: COVID-19; Drug Repositioning; Duloxetine Hydrochloride; Fatigue; Humans; Methylphenidate; Quinolones; Thiophenes | 2022 |
Top 20 Research Studies of 2021 for Primary Care Physicians.
Topics: Aged; Analgesics, Opioid; Anti-Bacterial Agents; Cardiovascular Diseases; Child; COVID-19; Diabetes Mellitus, Type 2; Duloxetine Hydrochloride; Female; Humans; Low Back Pain; Male; Pandemics; Physicians, Primary Care; Sodium-Glucose Transporter 2 Inhibitors | 2022 |